Tessera Therapeutics announced layoffs of 90 employees (approximately 35% of workforce) as part of pipeline prioritization. The Massachusetts-based biotech expects layoffs to begin March 8, 2026. No facilities will close. This follows a 17% reduction in 2025 and 13% downsizing in 2024.